
A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests.
The treatment could also delay the need for gruelling chemotherapy, according to a trial.

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests.
The treatment could also delay the need for gruelling chemotherapy, according to a trial.